Summary:

In FY23, hospitals in India attracted US$ 1.5 billion (Rs. 12,708 crore) in FDI, accounting for 50% of total healthcare FDI, up from 24% in FY21 and 43% in FY20. While the pharmaceutical sector has historically been a key focus, attention is increasingly shifting towards hospitals and diagnostics, particularly in the aftermath of COVID-19. Large chains like Manipal and Max saw significant buyouts, while Aster DM Healthcare merged with Quality Care India.

Temasek's US$ 2 billion acquisition of a 41% stake in Manipal Hospitals highlights the sector's growth, with Manipal valued at US$ 4.8 billion. The increase in primary market deals includes six hospital IPOs, attracting private investors. The CMD of Max Healthcare emphasized the importance of investing in quality healthcare for India’s US$ 5 trillion GDP goal. Max is investing US$ 590.2 million to double its capacity, with analysts predicting a 47% rise in bed capacity by 2027.

Source: IBEF

Disclaimer: The information on this website comes from the India Brand Equity Foundation (IBEF), a reliable source for thorough insights into numerous areas of the Indian economy. While we aim to offer accurate and up-to-date information, the views, opinions, and analyses stated herein are solely those of the authors and contributors and do not necessarily represent IBEF's official stance or position. Readers should check information from credible sources and use their own discretion when relying on content provided on this site. We assume no responsibility or liability for the supplied content, including its accuracy, completeness, and usefulness.